Indaptus Therapeutics INDP
NASDAQ INDP
$1.29 -0.09 (-6.52%)
At close: Aug 21, 2026 · 4:00 PM EDT

Indaptus Therapeutics (INDP) Change in Acquisitions & Divestments (2020 - 2023)

Indaptus Therapeutics (INDP) posted quarterly Change in Acquisitions & Divestments of $7.0 million for Q3 2023, down 12.5% quarter-over-quarter from $8.0 million in Q2 2023.

Indaptus Therapeutics (INDP) Change in Acquisitions & Divestments (2020 - 2023) Analysis & Trends

Indaptus Therapeutics' Change in Acquisitions & Divestments history runs 3 years deep, the most recent figure standing at $7.0 million for Q3 2023.

  • In Q3 2023, Change in Acquisitions & Divestments changed N/A year-over-year to $7.0 million; the TTM figure through Dec 2023 stood at $24.0 million (changed N/A YoY), while the FY2023 annual figure was $24.0 million, up 84.62% from the prior year.
  • Change in Acquisitions & Divestments for Q3 2023 stood at $7.0 million, down from $8.0 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $11.0 million in Q4 2022, with the low at $772000.0 in Q1 2020.
  • The 3-year median for Change in Acquisitions & Divestments is $8.0 million (2023), against an average of $7.2 million.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Indaptus Therapeutics 146.91 Mn 135.35 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2023 7.00 Mn
Sep 30, 2023 7.00 Mn
Jun 30, 2023 8.00 Mn
Jun 30, 2023 8.00 Mn
Mar 31, 2023 9.00 Mn
Mar 31, 2023 9.00 Mn
Dec 31, 2022 11.00 Mn
Dec 31, 2022 11.00 Mn
Mar 31, 2020 772,000.00
Mar 31, 2020 772,000.00